Compare EVLV & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVLV | QDEL |
|---|---|---|
| Founded | 2013 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 994.7M | 989.5M |
| IPO Year | 2020 | 2022 |
| Metric | EVLV | QDEL |
|---|---|---|
| Price | $4.96 | $10.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $9.13 | ★ $28.25 |
| AVG Volume (30 Days) | ★ 1.8M | 1.2M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 41.18 | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | $145,905,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $21.67 | $3.51 |
| Revenue Next Year | $19.50 | $3.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40.48 | N/A |
| 52 Week Low | $4.61 | $9.92 |
| 52 Week High | $8.81 | $35.58 |
| Indicator | EVLV | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 38.76 | 33.26 |
| Support Level | $4.86 | $9.92 |
| Resistance Level | $5.21 | $12.85 |
| Average True Range (ATR) | 0.17 | 0.71 |
| MACD | 0.01 | -0.20 |
| Stochastic Oscillator | 25.71 | 13.42 |
Evolv Technologies Holdings Inc is a security technology company pioneering Artificial Intelligence (AI)-powered screening solutions designed to help create safer environments while maintaining efficient visitor flow and a positive visitor experience. It serves customers across a range of end markets, including education, healthcare, sports, live entertainment, tourist attractions, houses of worship, and industrial workplaces. The company operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.